Bacillus Calmette-Guérin

Pharma

The FDA has cleared AZ's Imfinzi as part of the first immunotherapy combo regimen for patients with high-risk non-muscle-invasive bladder cancer.

Kevin Dunleavy May 28, 2026 4:39pm

May 3, 2024 10:50am